Alkalinization by Urologists & Nephrologists

• Status: Completed
• Trial end date: 2020-02-21
• Target enrollment: 0
• Participant gender: All

Summary

Metabolic acidosis recovers a wide range of diseases in which an oral alkalinization could be useful. This therapeutic intervention has been said to increase extracellular volume leading to rising blood pressure. No prospective data has been published in clinical routine. Here, investigators propose to follow patients in which an oral alkalinization is indicated: blood pressure, body weight, and a clinical evaluation of the extracellular compartment will be performed at the beginning and during the follow-up of participants. The principal criterion of evaluation will be the variation in the extracellular compartment.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Jean-Philippe Bertocchio

Criteria

Inclusion Criteria:

• > or = to 18 years old

• in whom an oral alkalinization is indicated

Exclusion Criteria:

• if the patient mentions its opposition to his/her enrollment